These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
713 related articles for article (PubMed ID: 20036603)
1. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922 [TBL] [Abstract][Full Text] [Related]
3. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958 [TBL] [Abstract][Full Text] [Related]
4. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901 [TBL] [Abstract][Full Text] [Related]
5. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518 [TBL] [Abstract][Full Text] [Related]
6. [Keratin 8 expression in mouth mucosa hyperkeratosis and squamous cell carcinoma ]. Babichenko II; Grigor'ian AS; Katushkina AA Arkh Patol; 2011; 73(6):18-21. PubMed ID: 22379894 [TBL] [Abstract][Full Text] [Related]
7. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. Ogmundsdóttir HM; Björnsson J; Holbrook WP J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450 [TBL] [Abstract][Full Text] [Related]
8. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias. Routray S; Kheur SM; Kheur M Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003 [TBL] [Abstract][Full Text] [Related]
11. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma. Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues. Fan GK; Chen J; Ping F; Geng Y Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. Sulkowska M; Famulski W; Chyczewski L; Sulkowski S Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700 [TBL] [Abstract][Full Text] [Related]
14. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia? Chen YK; Hsue SS; Lin LM Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192 [TBL] [Abstract][Full Text] [Related]
15. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. AbdulMajeed AA; Dalley AJ; Farah CS Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. Varun BR; Ranganathan K; Rao UK; Joshua E J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093 [TBL] [Abstract][Full Text] [Related]
17. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia]. Gao Y; Guo ZL; Luo HY; Wang J Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571 [TBL] [Abstract][Full Text] [Related]
19. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma]. Jiang Y; Wu Y; Wang F Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290 [TBL] [Abstract][Full Text] [Related]
20. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]